EviRed is proud to announce a key milestone in the project: the successful linkage of the EviRed cohort with the SNDS (French National Health Data System).
This major achievement significantly strengthens the value of the EVIRED RHU project. It enables the development of advanced medico-economic analyses and, in the longer term, will enhance our understanding of care pathways for patients living with diabetes.
We are pleased to announce that, as of February 24, the ANR has approved a six-month extension for the RHU Evired project.
This extension will enable the teams to finalise the remaining research work and enhance the performance of the artificial intelligence.
Stay connected to receive further information on the next steps of this exciting journey.
On February 6, 2026, the “RHU EVIRED Event Day” was held in Paris.
This meeting was distinguished by the diversity of its participants, bringing together experts in artificial intelligence, ophthalmologists, diabetologists, as well as members of the reading center and methodologists.
Discussions around the EVIRED project were particularly rich and constructive. They highlighted the high quality of the ongoing research work and opened up promising perspectives for the development of new ideas and future collaborations.
The EVIRED team would like to thank all participants for their active contributions, as well as everyone involved in the RHU EVIRED project, whose commitment and dedication have made the progress of this outstanding project possible.
The Eighth Annual FLORetina – ICOOR Congress was held this year from 4th to 7th December 2025 in Florence, Italy.
Each year, ophthalmologists and retina specialists from around the globe convene to discuss and debate the most pressing issues in the field of retinal medicine.
Evired was also present this year, Pr. Aude Couturier has delivered an oral presentation on the subject of “One-Year Progression from Severe Non-Proliferative to Proliferative Diabetic Retinopathy in the EviRed Study”.
EVIRED was proud to be present at the American Academy of Ophthalmology (AAO) 2025, held this year in Orlando US.
Professor Aude Couturier presented the preliminary results of the EVIRED study on the one-year progression of diabetic retinopathy towards the proliferative stage “One-Year Progression from Severe Non-Proliferative to Proliferative Diabetic Retinopathy in the Evired Study”
Her interview by Dr Isabelle Aknin for ARMD : https://urls.fr/TvKS2b
A great opportunity to share our work and discuss the future of AI-assisted evaluation of diabetic retinopathy within large national cohorts.
From October 3–5, 2025, the LaTIM team represented by Mostafa El Habib Daho & Gwenolé Quellec participated in the Fête de la Science at the “Musée des Arts et Métiers” in Paris, to showcase our groundbreaking work within the EviRed project.
We were thrilled to present our latest advancements in AI for retinal imaging and diabetic retinopathy management to the public. The insightful and thought-provoking questions from visitors highlighted the immense curiosity and enthusiasm for science and medical innovation.
A heartfelt thank you to everyone who visited our booth and engaged in such enriching discussions!
This work benefits from State aid managed by the National Research Agency under the investment program for the Future integrated to France 2030 bearing the reference ANR-18-RHUS-0008
